Elaine Sanij

Senior Research Fellow
Peter MacCallum Cancer Centre

Melbourne, VIC

Contact me for

  • Mentoring
  • Sitting on boards or committees
  • Providing an expert opinion
  • Outreach activities
  • Conference presenting
  • Opportunities to collaborate


Dr. Elaine Sanij received her PhD from Monash University in 2003 and was awarded a Cancer Research UK Postdoctoral Fellowship to undertake research at the London Research Institute, Cancer Research UK. Elaine joined Peter Mac in 2006 and she is a Senior Research Fellow in the Oncogenic Signalling & Growth Control Program. Elaine made seminal contributions to the understanding of the role of RNA Polymerase I transcription of ribosomal RNA genes in tumourigenesis and to the development of the first-in-class Pol I inhibitor CX-5461 as an anti-tumour agent that is currently in 2 international phase I/II clinical trials in patients with haematological malignancies (Peter Mac) and breast cancer (Canadian Cancer Trials Group).  

Her current studies demonstrate therapeutic benefit for CX-5461 against high-grade serous ovarian cancer. In 2018, Dr Sanij was the recipient of the prestigious highly commended Peter Mac Lea Award, which recognises emerging female research leaders and was the inaugural participant in a cancer research exchange program with the Dana-Farber Cancer Institute in Boston to establish collaborations in novel DNA repair therapies in ovarian cancer. Elaine is currently the Chair of the research division gender equity committee and a member of the Women In Science Parkville Precinct (WiSPP) committee and she is passionate about improving gender equality and female representation at the senior level and in leadership roles within the precinct.


Elaine identifies as culturally and linguistically diverse.